ArticleCell death & disease2026
The EHMT2-MBLAC2 axis suppresses ribosomal DNA transcription in response to nucleolar DNA damage.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
The induction of DNA double-strand breaks (DSBs) within actively transcribed ribosomal DNA (rDNA) arrays triggers transcriptional suppression and drives nucleolar reorganization, including the formation of nucleolar caps that facilitate the engagement of DSBs with canonical DSB signaling and repair proteins. Although these nucleolar responses are critical for rDNA stability, the components that orchestrate these responses remain unclear. In this study, we identified euchromatic histone-lysine N-methyltransferase 2 (EHMT2) as a novel regulator that is essential for rDNA DSB-induced transcriptional suppression, while functioning independently of ATM-mediated nucleolar responses. We found that EHMT2 is required for the repair of rDNA DSBs and the maintenance of rDNA stability, and its deficiency can result in cellular hypersensitivity to rDNA DSBs. Global proteomic analysis revealed that EHMT2 interacts with MBLAC2 to repress rDNA transcription upon rDNA DSBs. The depletion of EHMT2 or MBLAC2 sensitized colorectal cancer cells to ribosomal stress. Furthermore, we uncovered that EHMT2 promotes colorectal tumorigenesis, revealing a novel mechanistic link between rDNA transcriptional regulation and tumor promotion. Together, our findings established the EHMT2-MBLAC2 axis as a pivotal regulator of mammalian rDNA DSB-induced transcriptional silencing that coordinates rDNA DSB repair and the maintenance of rDNA integrity during nucleolar damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.